231 related articles for article (PubMed ID: 20838239)
1. Distribution and expression of picalm in Alzheimer disease.
Baig S; Joseph SA; Tayler H; Abraham R; Owen MJ; Williams J; Kehoe PG; Love S
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1071-7. PubMed ID: 20838239
[TBL] [Abstract][Full Text] [Related]
2. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
Thomas RS; Henson A; Gerrish A; Jones L; Williams J; Kidd EJ
BMC Neurosci; 2016 Jul; 17(1):50. PubMed ID: 27430330
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM
J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346
[TBL] [Abstract][Full Text] [Related]
4. Genetics of PICALM expression and Alzheimer's disease.
Parikh I; Fardo DW; Estus S
PLoS One; 2014; 9(3):e91242. PubMed ID: 24618820
[TBL] [Abstract][Full Text] [Related]
5. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
[TBL] [Abstract][Full Text] [Related]
6. The role of PTB domain containing adaptor proteins on PICALM-mediated APP endocytosis and localization.
Merthan L; Haller A; Thal DR; von Einem B; von Arnim CAF
Biochem J; 2019 Jul; 476(14):2093-2109. PubMed ID: 31300465
[TBL] [Abstract][Full Text] [Related]
7. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.
Zhao Z; Sagare AP; Ma Q; Halliday MR; Kong P; Kisler K; Winkler EA; Ramanathan A; Kanekiyo T; Bu G; Owens NC; Rege SV; Si G; Ahuja A; Zhu D; Miller CA; Schneider JA; Maeda M; Maeda T; Sugawara T; Ichida JK; Zlokovic BV
Nat Neurosci; 2015 Jul; 18(7):978-87. PubMed ID: 26005850
[TBL] [Abstract][Full Text] [Related]
8. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
9. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.
Tian Y; Chang JC; Fan EY; Flajolet M; Greengard P
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17071-6. PubMed ID: 24067654
[TBL] [Abstract][Full Text] [Related]
10. PICALM and Alzheimer's Disease: An Update and Perspectives.
Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
[TBL] [Abstract][Full Text] [Related]
11. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.
Ando K; Brion JP; Stygelbout V; Suain V; Authelet M; Dedecker R; Chanut A; Lacor P; Lavaur J; Sazdovitch V; Rogaeva E; Potier MC; Duyckaerts C
Acta Neuropathol; 2013 Jun; 125(6):861-78. PubMed ID: 23589030
[TBL] [Abstract][Full Text] [Related]
12. The Role of PICALM in Alzheimer's Disease.
Xu W; Tan L; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):399-413. PubMed ID: 25186232
[TBL] [Abstract][Full Text] [Related]
13. PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.
Kumon H; Yoshino Y; Funahashi Y; Mori H; Ueno M; Ozaki Y; Yamazaki K; Ochi S; Mori T; Iga JI; Nagai M; Nomoto M; Ueno SI
J Alzheimers Dis; 2021; 79(3):1055-1062. PubMed ID: 33386803
[TBL] [Abstract][Full Text] [Related]
14. Partial loss of CALM function reduces Aβ42 production and amyloid deposition in vivo.
Kanatsu K; Hori Y; Takatori S; Watanabe T; Iwatsubo T; Tomita T
Hum Mol Genet; 2016 Sep; 25(18):3988-3997. PubMed ID: 27466196
[TBL] [Abstract][Full Text] [Related]
15. Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase.
Kanatsu K; Morohashi Y; Suzuki M; Kuroda H; Watanabe T; Tomita T; Iwatsubo T
Nat Commun; 2014 Feb; 5():3386. PubMed ID: 24577224
[TBL] [Abstract][Full Text] [Related]
16. Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiology.
Ishikawa Y; Maeda M; Pasham M; Aguet F; Tacheva-Grigorova SK; Masuda T; Yi H; Lee SU; Xu J; Teruya-Feldstein J; Ericsson M; Mullally A; Heuser J; Kirchhausen T; Maeda T
Haematologica; 2015 Apr; 100(4):439-51. PubMed ID: 25552701
[TBL] [Abstract][Full Text] [Related]
17. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
[TBL] [Abstract][Full Text] [Related]
18. The PICALM protein plays a key role in iron homeostasis and cell proliferation.
Scotland PB; Heath JL; Conway AE; Porter NB; Armstrong MB; Walker JA; Klebig ML; Lavau CP; Wechsler DS
PLoS One; 2012; 7(8):e44252. PubMed ID: 22952941
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina.
Chen J; Pikuleva IA; Turko IV
Anal Biochem; 2013 Nov; 442(2):253-8. PubMed ID: 23954523
[TBL] [Abstract][Full Text] [Related]
20. Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
Thomas RS; Alsaqati M; Bice JS; Hvoslef-Eide M; Good MA; Kidd EJ
Neuroreport; 2017 Oct; 28(15):963-968. PubMed ID: 28885485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
